In connection with the implementation of the project titled “Design and development of nanoparticle-RNA based drugs to be used in anti-cancer therapy with the construction of a nanoparticle platform for targeted delivery of therapeutic nucleic acids”, carried out by Biotechna SA under agreement no. 2022/ABM/06/00005-00 for the co-financing of a Commercial Project within the Competition for the development of targeted or personalized medicine based on nucleic acid-based and small molecule medicinal products, the Contracting Authority is conducting a market inquiry regarding the costs of purchase and delivery of HCC1143 cell lines.
To submit a bid, please review the detailed announcement below in Request for quotation 87/2025 and submit a completed offer form and assortment and pricing form.